FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020158514> ?p ?o ?g. }

• W2020158514 endingPage "2357" @default.
• W2020158514 startingPage "2348" @default.
• W2020158514 abstract "Overexpression of epidermal growth factor receptor (EGFR) is found in over 80% of head and neck squamous cell carcinomas (HNSCC) and associated with poor clinical outcomes. EFGR selective tyrosine kinase inhibitors (TKIs) or antibodies have recently emerged as promising treatments for solid tumors, including HNSCC, though the response rate to these agents is low. p53 upregulated modulator of apoptosis (PUMA), a BH3-only Bcl-2 family protein, is required for apoptosis induced by p53 and various chemotherapeutic agents. In this study, we show that PUMA induction is correlated with EGFR-TKI sensitivity, and is mediated through the p53 family protein p73beta and inhibition of the PI3K/AKT pathway. In some HNSCC cells, the gefitinib-induced degradation of oncogenic Delta Np63 seems to facilitate p73-mediated PUMA transcription. Inhibiting PUMA expression by small hairpin RNA (shRNA) impairs gefitinib-induced apoptosis. Furthermore, PUMA or BH3 mimetics sensitize HNSCC cells to gefitinib-induced apoptosis. Our results suggest that PUMA induction through p73 represents a new mechanism of EGFR inhibitor-induced apoptosis, and provide potential ways for enhancing and predicting the sensitivity to EGFR-targeted therapies in HNSCC." @default.
• W2020158514 created "2016-06-24" @default.
• W2020158514 creator A5019759735 @default.
• W2020158514 creator A5028963094 @default.
• W2020158514 creator A5066378974 @default.
• W2020158514 creator A5067153932 @default.
• W2020158514 creator A5081860481 @default.
• W2020158514 creator A5082035812 @default.
• W2020158514 creator A5086074491 @default.
• W2020158514 creator A5086910766 @default.
• W2020158514 creator A5088286120 @default.
• W2020158514 date "2009-05-04" @default.
• W2020158514 modified "2023-10-10" @default.
• W2020158514 title "PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells" @default.
• W2020158514 cites W1796205058 @default.
• W2020158514 cites W1965734230 @default.
• W2020158514 cites W1966895787 @default.
• W2020158514 cites W1973294295 @default.
• W2020158514 cites W1978259246 @default.
• W2020158514 cites W1980727670 @default.
• W2020158514 cites W1982097971 @default.
• W2020158514 cites W1989190896 @default.
• W2020158514 cites W1995242599 @default.
• W2020158514 cites W2000080731 @default.
• W2020158514 cites W2000541314 @default.
• W2020158514 cites W2008715871 @default.
• W2020158514 cites W2011024702 @default.
• W2020158514 cites W2016710415 @default.
• W2020158514 cites W2023597079 @default.
• W2020158514 cites W2026177159 @default.
• W2020158514 cites W2028181497 @default.
• W2020158514 cites W2032526895 @default.
• W2020158514 cites W2032603938 @default.
• W2020158514 cites W2034269086 @default.
• W2020158514 cites W2042850275 @default.
• W2020158514 cites W2047160541 @default.
• W2020158514 cites W2061446835 @default.
• W2020158514 cites W2064074669 @default.
• W2020158514 cites W2068025977 @default.
• W2020158514 cites W2069148122 @default.
• W2020158514 cites W2082811086 @default.
• W2020158514 cites W2087369364 @default.
• W2020158514 cites W2089082314 @default.
• W2020158514 cites W2089663915 @default.
• W2020158514 cites W2091879550 @default.
• W2020158514 cites W2097005995 @default.
• W2020158514 cites W2100626226 @default.
• W2020158514 cites W2102088611 @default.
• W2020158514 cites W2112968535 @default.
• W2020158514 cites W2114078657 @default.
• W2020158514 cites W2122624068 @default.
• W2020158514 cites W2129361942 @default.
• W2020158514 cites W2148220182 @default.
• W2020158514 cites W2151414819 @default.
• W2020158514 cites W2152636515 @default.
• W2020158514 cites W2155384808 @default.
• W2020158514 cites W2157805786 @default.
• W2020158514 cites W2166864956 @default.
• W2020158514 doi "https://doi.org/10.1038/onc.2009.108" @default.
• W2020158514 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2872091" @default.
• W2020158514 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19421143" @default.
• W2020158514 hasPublicationYear "2009" @default.
• W2020158514 type Work @default.
• W2020158514 sameAs 2020158514 @default.
• W2020158514 citedByCount "58" @default.
• W2020158514 countsByYear W20201585142012 @default.
• W2020158514 countsByYear W20201585142013 @default.
• W2020158514 countsByYear W20201585142014 @default.
• W2020158514 countsByYear W20201585142015 @default.
• W2020158514 countsByYear W20201585142016 @default.
• W2020158514 countsByYear W20201585142017 @default.
• W2020158514 countsByYear W20201585142018 @default.
• W2020158514 countsByYear W20201585142019 @default.
• W2020158514 countsByYear W20201585142020 @default.
• W2020158514 countsByYear W20201585142021 @default.
• W2020158514 countsByYear W20201585142022 @default.
• W2020158514 crossrefType "journal-article" @default.
• W2020158514 hasAuthorship W2020158514A5019759735 @default.
• W2020158514 hasAuthorship W2020158514A5028963094 @default.
• W2020158514 hasAuthorship W2020158514A5066378974 @default.
• W2020158514 hasAuthorship W2020158514A5067153932 @default.
• W2020158514 hasAuthorship W2020158514A5081860481 @default.
• W2020158514 hasAuthorship W2020158514A5082035812 @default.
• W2020158514 hasAuthorship W2020158514A5086074491 @default.
• W2020158514 hasAuthorship W2020158514A5086910766 @default.
• W2020158514 hasAuthorship W2020158514A5088286120 @default.
• W2020158514 hasBestOaLocation W20201585141 @default.
• W2020158514 hasConcept C121608353 @default.
• W2020158514 hasConcept C173396325 @default.
• W2020158514 hasConcept C190232843 @default.
• W2020158514 hasConcept C190283241 @default.
• W2020158514 hasConcept C2776530083 @default.
• W2020158514 hasConcept C2776833033 @default.
• W2020158514 hasConcept C2777417711 @default.
• W2020158514 hasConcept C2777506169 @default.
• W2020158514 hasConcept C2778820342 @default.
• W2020158514 hasConcept C2779438470 @default.
• W2020158514 hasConcept C2780580887 @default.

• next